‌

US Patent 9345709 1,5-naphthyridine derivatives and MELK inhibitors containing the same

Patent 9345709 was granted and assigned to OncoTherapy Science, Inc. on May, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

OncoTherapy Science, Inc.

Current Assignee

OncoTherapy Science, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

93457090

Patent Inventor Names

Raymond Huntley0

Yusuke Nakamura0

Yo Matsuo0

Feryan Ahmed0

Joel R. Walker0

Shoji Hisada0

Date of Patent

May 24, 2016

Patent Application Number

147190750

Date Filed

May 21, 2015

Patent Primary Examiner

‌

Niloofar Rahmani

Patent abstract

The present invention directs a compound represented by formula (I).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9345709 1,5-naphthyridine derivatives and MELK inhibitors containing the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API